Australia's PYC Therapeutics rises on successful neurodevelopmental drug test

PYC Therapeutics

07/06/2024 02:45

** Shares of PYC Therapeutics  PYC.AX  rise as much as 10%
to A$0.110, hitting their highest level since May 30
    ** Biotechnology co says its fourth drug candidate for
neurodevelopmental disorder found effective in human brain cells
derived from patient
    ** Says it will now progress towards initiating studies
required to enter human trials
    ** Stock down 8% this year, as of last close

 (Reporting by Shivangi Lahiri in Bengaluru)
 ((shivangi.lahiri@thomsonreuters.com))